Bleichroeder II Launches $250M SPAC IPO, Eyes Disruptive Growth

TL;DR

**BBCQW is a high-risk SPAC with significant sponsor dilution and potential conflicts, so proceed with extreme caution.**

AI Summary

Bleichroeder Acquisition Corp. II (BBCQW) is launching an initial public offering of 25,000,000 units at $10.00 per unit, aiming to raise $250,000,000. Each unit comprises one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable at $11.50 per share. The SPAC intends to target North American and European businesses in disruptive growth sectors, leveraging its management's operational and investment expertise. The sponsor, Bleichroeder Sponsor 2 LLC, and Cohen & Company Capital Markets will purchase 7,750,000 private placement warrants for $7,750,000. Founder shares, held by the sponsor, represent approximately 25% of the ordinary shares outstanding post-offering, purchased at a nominal price of $0.003 per share, creating potential dilution for public shareholders. The company will repay up to $500,000 in loans from its sponsor for offering-related expenses and may convert up to $2,000,000 in working capital loans into warrants at $1.00 per warrant, further increasing potential dilution. Monthly fees of $25,000 will be paid to an affiliate of the Chief Operating Officer until a business combination or liquidation.

Why It Matters

This S-1 filing signals Bleichroeder Acquisition Corp. II's entry into the SPAC market, offering investors a chance to participate in a blank-check company targeting disruptive growth sectors in North America and Europe. The significant founder share ownership (25%) at a nominal price, coupled with potential warrant dilution from the sponsor and working capital loans, creates a notable risk for public shareholders. Competitively, this SPAC will vie with numerous other blank-check companies for attractive private targets, making its management's stated expertise critical for success. Investors need to weigh the potential for a high-growth acquisition against the substantial dilution risks and potential conflicts of interest.

Risk Assessment

Risk Level: high — The risk level is high due to several factors: the sponsor purchased 9,583,333 Class B ordinary shares for a nominal $25,000, or approximately $0.003 per share, which represents 25% of all ordinary shares post-offering, creating substantial dilution potential. Additionally, up to $2,000,000 in working capital loans from the sponsor may be convertible into warrants at $1.00 per warrant, further diluting public shareholders. The filing explicitly states, "The low price that our sponsor, executive officers and directors (directly or indirectly) paid for the founder shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders."

Analyst Insight

Investors should carefully evaluate the substantial dilution risks from founder shares and private placement warrants, as well as potential conflicts of interest with the sponsor and management. Consider waiting until a target business is identified and thoroughly scrutinize the terms of any proposed business combination before investing. The current structure heavily favors the sponsor.

Financial Highlights

debt To Equity

0.0

revenue

$0

operating Margin

N/A

total Assets

$250,000,000

total Debt

$0

net Income

$0

eps

$0.00

gross Margin

N/A

cash Position

$250,000,000

revenue Growth

N/A

Key Numbers

• $250,000,000 — Total Offering Size (Amount expected to be raised from the IPO of 25,000,000 units at $10.00 each.)
• 25,000,000 — Units Offered (Number of units being sold in the initial public offering.)
• $10.00 — Price Per Unit (The offering price for each unit in the IPO.)
• 7,750,000 — Private Placement Warrants (Number of warrants purchased by the sponsor and CCM for $7,750,000.)
• $11.50 — Warrant Exercise Price (The price at which each whole warrant can be exercised to purchase one Class A ordinary share.)
• 9,583,333 — Class B Ordinary Shares (Number of founder shares purchased by the sponsor.)
• $0.003 — Per Share Price for Founder Shares (The nominal price paid by the sponsor for Class B ordinary shares.)
• 25% — Sponsor Ownership (Approximate percentage of ordinary shares owned by the sponsor post-offering on an as-converted basis.)
• $500,000 — Sponsor Loan Repayment (Maximum amount of loans from the sponsor to be repaid for offering-related expenses.)
• $2,000,000 — Convertible Working Capital Loans (Maximum amount of working capital loans from the sponsor convertible into warrants at $1.00 per warrant.)

Key Players & Entities

• Bleichroeder Acquisition Corp. II (company) — Registrant and SPAC issuing units
• Andrew Gundlach (person) — Chief Executive Officer of Bleichroeder Acquisition Corp. II
• Bleichroeder Sponsor 2 LLC (company) — Sponsor of Bleichroeder Acquisition Corp. II
• Cohen & Company Capital Markets (company) — Representative of the underwriters and private placement warrant purchaser
• Ellenoff Grossman & Schole LLP (company) — Legal counsel for the registrant
• Ogier (Cayman) LLP (company) — Cayman Islands legal counsel for the registrant
• Reed Smith LLP (company) — Legal counsel for the registrant
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
• Inflation Reduction Act of 2022 (regulator) — Legislation impacting potential excise tax on redemptions
• Nasdaq (regulator) — Stock exchange for listing eligibility requirements

FAQ

Risk Factors

• Dilution from Sponsor Shares and Warrants [high — financial]: The sponsor, Bleichroeder Sponsor 2 LLC, holds 9,583,333 founder shares, representing approximately 25% of the ordinary shares outstanding post-offering, acquired at a nominal price of $0.003 per share. Additionally, the sponsor and Cohen & Company Capital Markets (CCM) are purchasing 7,750,000 private placement warrants. The potential conversion of up to $2,000,000 in working capital loans into warrants at $1.00 per warrant further increases the potential dilution for public shareholders.
• Ongoing Sponsor Fees [medium — operational]: An affiliate of the Chief Operating Officer will receive monthly fees of $25,000 until a business combination or liquidation. This ongoing expense represents a drain on capital that could otherwise be used for business development or returned to shareholders.
• Limited Operating History and No Target [high — financial]: As a newly formed blank check company, Bleichroeder Acquisition Corp. II has no operating history and has not yet identified or entered into substantive discussions with a target business. This lack of a defined strategy or target introduces significant uncertainty regarding the company's future prospects and the success of any potential business combination.
• Redemption Risk and Trust Account Depletion [medium — market]: Public shareholders have the right to redeem their shares upon a business combination. If a significant portion of shareholders exercise this right, it could deplete the trust account, potentially leaving insufficient funds for the business combination or impacting the company's ability to operate post-combination.
• Potential Excise Tax on Redemptions [low — regulatory]: The proceeds in the trust account will not be used to pay for potential excise taxes levied on redemptions or share buybacks, such as those under the Inflation Reduction Act of 2022. This could reduce the net proceeds available to shareholders upon redemption.

Industry Context

Bleichroeder Acquisition Corp. II aims to target North American and European businesses in disruptive growth sectors, particularly those being transformed by technology adoption. This focus aligns with a broader market trend where SPACs are increasingly seeking targets in high-growth, innovative industries. The competitive landscape for identifying and acquiring such targets is intense, with numerous SPACs vying for attractive businesses.

Regulatory Implications

As a Cayman Islands exempted company conducting a U.S. IPO, Bleichroeder Acquisition Corp. II is subject to SEC regulations, including disclosure requirements under the Securities Act of 1933 and the Exchange Act. Potential excise taxes on redemptions, as introduced by legislation like the Inflation Reduction Act of 2022, represent a developing regulatory risk that could impact shareholder returns.

What Investors Should Do

1. Scrutinize the sponsor's economic interest and potential dilution.
2. Evaluate the management team's expertise in identifying and executing deals in 'disruptive growth sectors'.
3. Understand the redemption rights and potential impact on trust account value.
4. Monitor the ongoing sponsor fees and their impact on deployable capital.

Key Dates

• 2025-10-15: Filing of S-1 Registration Statement — This marks the initial public filing for Bleichroeder Acquisition Corp. II's IPO, providing detailed information about the offering and the company's structure.

Glossary

Blank Check Company

A shell corporation that is set up to acquire or merge with an existing company, often without a specific target identified at the time of its own IPO. (Bleichroeder Acquisition Corp. II is structured as a blank check company, meaning its primary purpose is to find and merge with another business.)

Units

A security that combines two or more different types of securities, typically shares and warrants, offered together as a single package. (The IPO is structured as a sale of units, each containing one Class A ordinary share and one-third of a redeemable warrant.)

Redeemable Warrant

A financial instrument that gives the holder the right, but not the obligation, to purchase a company's stock at a specified price (exercise price) before a certain expiration date. (These warrants are part of the units and can be exercised by holders to buy Class A ordinary shares, potentially increasing the company's capital but also diluting existing shareholders.)

Sponsor

An entity that typically invests in a SPAC before its IPO, often receiving founder shares and private placement warrants in exchange for their capital and expertise. (Bleichroeder Sponsor 2 LLC is the sponsor, holding founder shares and participating in private warrant purchases, which carries significant dilution implications.)

Founder Shares

Shares of ordinary stock typically issued to the SPAC's sponsor at a nominal price before the IPO, often carrying voting rights and representing a significant equity stake. (The sponsor's founder shares represent a substantial portion of the post-offering equity, leading to potential dilution for public investors.)

Trust Account

A segregated account where the proceeds from a SPAC's IPO are held in trust, typically invested in U.S. Treasury securities, until a business combination is completed or the SPAC liquidates. (The funds in the trust account are crucial for the business combination and for providing redemption proceeds to public shareholders.)

Business Combination

The merger, acquisition, share exchange, or similar transaction through which a SPAC combines with an operating company. (The SPAC's primary objective is to complete a business combination within a specified timeframe.)

Year-Over-Year Comparison

This is the initial S-1 filing for Bleichroeder Acquisition Corp. II, therefore, there are no prior filings to compare key metrics against. All financial data presented pertains to the pre-IPO stage, with the primary financial highlights being the offering size of $250,000,000 and the cash position expected from the IPO proceeds held in trust. No revenue, net income, or operating margins are applicable at this stage.

Key Financial Figures

• $250,000,000 B — TO COMPLETION, DATED OCTOBER 15, 2025 $250,000,000 Bleichroeder Acquisition Corp. II 25,00
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $7,750,000 — ull) for an aggregate purchase price of $7,750,000 (whether or not the underwriters' over
• $500,000 — ring or thereafter, we will repay up to $500,000 in loans made to us by our sponsor to c
• $2,000,000 — our initial business combination, up to $2,000,000 of such loans may be convertible into w
• $1.00 — siness combination entity at a price of $1.00 per warrant at the option of our sponso
• $25,000 — ffiliate of our Chief Operating Officer $25,000 per month for his services as Chief Ope
• $100,000 — (less taxes, if any, payable and up to $100,000 of interest income to pay dissolution e
• $0.20 — 235,000,000 ____________ (1) Includes $0.20 per unit (excluding any units sold purs
• $5,000,000 — ption to purchase additional units), or $5,000,000 in the aggregate (whether or not the un
• $0.40 — closing of this offering. Also includes $0.40 per unit on units other than those sold
• $0.60 — option to purchase additional units and $0.60 per unit on units sold pursuant to the
• $10,000,000 — to purchase additional units, or up to $10,000,000 in the aggregate or up to $12,250,000 i
• $12,250,000 — o $10,000,000 in the aggregate or up to $12,250,000 in the aggregate if the underwriters' o

Filing Documents

• ea0260687-01.htm (S-1) — 4248KB
• ea026068701ex3-1i_bleich.htm (EX-3.1(I)) — 30KB
• ea026068701ex3-1ii_bleich.htm (EX-3.1(II)) — 632KB
• ea026068701ex4-4_bleich.htm (EX-4.4) — 151KB
• ea026068701ex10-7_bleich.htm (EX-10.7) — 19KB
• ea026068701ex10-8_bleich.htm (EX-10.8) — 53KB
• ea026068701ex23-1_bleich.htm (EX-23.1) — 2KB
• ea026068701ex99-3_bleich.htm (EX-99.3) — 3KB
• ea026068701ex99-4_bleich.htm (EX-99.4) — 3KB
• ea026068701ex-fee_bleich.htm (EX-FILING FEES) — 22KB
• ex3-1i_001.jpg (GRAPHIC) — 4KB
• ex3-1i_002.jpg (GRAPHIC) — 1KB
• ex3-1i_003.jpg (GRAPHIC) — 2KB
• ex3-1ii_001.jpg (GRAPHIC) — 12KB
• ex3-1ii_002.jpg (GRAPHIC) — 15KB
• ex3-1ii_003.jpg (GRAPHIC) — 2KB
• 0001213900-25-099179.txt ( ) — 8810KB
• bacq-20251015.xsd (EX-101.SCH) — 8KB
• bacq-20251015_def.xml (EX-101.DEF) — 13KB
• bacq-20251015_lab.xml (EX-101.LAB) — 118KB
• bacq-20251015_pre.xml (EX-101.PRE) — 72KB
• ea0260687-01_htm.xml (XML) — 1173KB
• ea026068701ex-fee_bleich_htm.xml (XML) — 10KB

From the Filing

As filed with the U.S. Securities and Exchange Commission on October 15, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ___________________________________ Bleichroeder Acquisition Corp. II (Exact name of registrant as specified in its charter) ___________________________________ Cayman Islands 6770 98-1888010 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 1345 Avenue of the Americas, Fl 47 New York, NY 10105 212-984-3835 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) ___________________________________ Andrew Gundlach Chief Executive Officer 1345 Avenue of the Americas, Fl 47 New York, NY 10105 212-984-3835 (Name, address, including zip code, and telephone number, including area code, of agent for service) ___________________________________ Copies to: Douglas S. Ellenoff Stuart Neuhauser Ellenoff Grossman & Schole LLP 1345 Avenue of the Americas, 11 th Floor New York, New York 10105 (212) 370-1300 Bradley Kruger Ogier (Cayman) LLP 89 Nexus Way, Camana Bay, Grand Cayman Cayman Islands KY1 -9009 (345) 949 -9876 Lynwood E. Reinhardt Jr. Anne G. Peetz Yuta N. Delarck Reed Smith LLP 2850 N. Harwood Street Suite 1500 Dallas, Texas 75201 (469) 680 -4200 ___________________________________ Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. Table of Contents The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. PRELIMINARY PROSPECTUS $250,000,000 Bleichroeder Acquisition Corp. II 25,000,000 Units ___________________________________ Bleichroeder Acquisition Corp. II is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target, and we have not, nor has anyone on our behalf, initiated any substant

View Full Filing

View this S-1 filing on SEC EDGAR